Archive: September 2015
Feature Article
Monoclonal Antibodies in Myeloma
Clinical Advances in Hematology & Oncology Volume 13, Issue 9, September 2015 Pia Sondergeld, PhD, Niels W. C. J. van de Donk, MD, PhD, Paul G. Richardson, […]
Feature Article
New Insights Into Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia: A 2015 Perspective
Fabienne McClanahan, MD, PhD, and John Gribben, MD, DSc, FRCP, FRCPath, FMedSci Dr McClanahan is a Clinical Research Fellow in the Centre for Haemato-Oncology at the […]
Counterpoints
Is There a Clinical Role for Molecular Phenotyping in Atypical Presentation of Metastatic Castration-Resistant Prostate Cancer?
Now that our understanding of potentially actionable mutations has increased, is it time for physicians to look into molecular phenotyping for their patients with metastatic castration-resistant […]
Advances in LLM
FLT3 Inhibitors for Acute Myeloid Leukemia
Jeffrey E. Lancet, MD Senior Member and Professor of Oncologic Sciences Moffitt Cancer Center University of South Florida College of Medicine Tampa, Florida H&O What […]
Prostate Cancer In Focus
The Timing of Radium-223 Therapy in Castration-Resistant Prostate Cancer
Clinical Advances in Hematology & Oncology Volume 13, Issue 9, September 2015 Oliver Sartor, MD LaBorde Professor for Cancer Research Medical Director Tulane Cancer Center Departments of […]
Advances in Hematology
Contraception in Women With Hereditary Thrombophilic Defects
Michiel Coppens, MD, PhD Internist, Vascular Medicine Academic Medical Center Amsterdam, The Netherlands H&O How common is thrombophilia in women of childbearing age? MC The term thrombophilia […]
Advances in Drug Development
The Value and Effectiveness of Angiogenesis Inhibitors for Colorectal Cancer
Alan P. Venook, MD The Madden Family Distinguished Professor of Medical Oncology and Translational Research School of Medicine University of California, San Francisco H&O What […]
Breast Cancer In Focus
What Is the Optimal Way to Evaluate Quality of Life in Breast Cancer Trials?
Patricia A. Ganz, MD Professor of Medicine David Geffen School of Medicine at UCLA Los Angeles, California H&O What are the main quality-of-life issues faced […]
Hem/Onc News
September News
Hem/Onc News By Devon Schuyler Use of Intraperitoneal Chemotherapy in Ovarian Cancer Is Limited Fewer than half of women with stage III ovarian cancer receive intraperitoneal […]
Letter From the Editor
Letter From the Editor: What I Did On My Summer Vacation
My wife and I recently returned from our remarkable, 2-week, active summer vacation—one that I highly recommend. The journey began in Berlin, where we met some […]